---
path: https://www.nytimes.com/2020/05/04/business/coronavirus-china-vaccine.html
date: 2020-05-20T19:21:33.427Z
title: Sinopharm
---
Sinopharm is currently at phase I/II trials. Although, this company does not seem to have a lot of credibility for their products especially in China where they already had court cases about their products not being reliable.